Kettering Health Main Campus

Kettering, Ohio 45429

1 studies enrolling now · 6 studies all time

What they study most

Cervical Cancer, Clear Cell Renal Cell Carcinoma, Glioma (Any Grade) in the Brain, Kernicterus, Moderate Aortic Valve Stenosis, Neonatal Opiate Withdrawal Syndrome, Neonatal Screening, Newborn Jaundice, Point-of-Care Testing

Studies at this site

• Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer — Recruiting now
• 89Zr-DFO-girentuximab Expanded Access Program (EAP) — NO_LONGER_AVAILABLE
• 18F-Floretyrosine Expanded Access Program — NO_LONGER_AVAILABLE
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
• Optimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach — Completed
• Bilistick Point-of-care System 2.0 Bilirubin Validation — Completed